Related references
Note: Only part of the references are listed.Understanding the significance of cytokines and chemokines in the pathogenesis of alopecia areata
Taisuke Ito et al.
EXPERIMENTAL DERMATOLOGY (2020)
An Open-Label Pilot Study to Evaluate the Efficacy of Tofacitinib in Moderate to Severe Patch-Type Alopecia Areata, Totalis, and Universalis
A. Jabbari et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2018)
Vitiligo Skin Is Imprinted with Resident Memory CD8 T Cells Expressing CXCR3
Katia Boniface et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2018)
Primary analysis of a phase II open-label trial of INCB039110, a selective JAK1 inhibitor, in patients with myelofibrosis
John O. Mascarenhas et al.
HAEMATOLOGICA (2017)
Primary analysis of a phase II open-label trial of INCB039110, a selective JAK1 inhibitor, in patients with myelofibrosis
John O. Mascarenhas et al.
HAEMATOLOGICA (2017)
CD49a Expression Defines Tissue-Resident CD8+ T Cells Poised for Cytotoxic Function in Human Skin
Stanley Cheuk et al.
IMMUNITY (2017)
Evaluation of JAK3 Biology in Autoimmune Disease Using a Highly Selective, Irreversible JAK3 Inhibitor
Fiona Elwood et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2017)
JAK inhibition as a therapeutic strategy for immune and inflammatory diseases
Daniella M. Schwartz et al.
NATURE REVIEWS DRUG DISCOVERY (2017)
Canonical and Non-Canonical Aspects of JAK-STAT Signaling: Lessons from interferons for Cytokine Responses
Andrea Majoros et al.
Frontiers in Immunology (2017)
Alopecia areata
C. Herbert Pratt et al.
NATURE REVIEWS DISEASE PRIMERS (2017)
Targeting JAK/STAT signalling in inflammatory skin diseases with small molecule inhibitors
Katharina Welsch et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2017)
Specificity of JAK-kinase inhibition determines impact on human and murine T-cell function
F. Perner et al.
LEUKEMIA (2016)
Discovery of a JAK3-Selective Inhibitor: Functional Differentiation of JAK3-Selective Inhibition over pan-JAK or JAK1-Selective Inhibition
Jean-Baptiste Telliez et al.
ACS CHEMICAL BIOLOGY (2016)
A randomized, double-blind, placebo-controlled, dose-escalation study of the safety and efficacy of INCB039110, an oral janus kinase 1 inhibitor, in patients with stable, chronic plaque psoriasis
Robert Bissonnette et al.
JOURNAL OF DERMATOLOGICAL TREATMENT (2016)
CXCR3 Blockade Inhibits T Cell Migration into the Skin and Prevents Development of Alopecia Areata
Zhenpeng Dai et al.
JOURNAL OF IMMUNOLOGY (2016)
Essential biphasic role for JAK3 catalytic activity in IL-2 receptor signaling
Geoffrey A. Smith et al.
NATURE CHEMICAL BIOLOGY (2016)
Oral ruxolitinib induces hair regrowth in patients with moderate-to-severe alopecia areata
Julian Mackay-Wiggan et al.
JCI INSIGHT (2016)
The role of lymphocytes in the development and treatment of alopecia areata
Hongwei Guo et al.
EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2015)
Resident memory T cells in human health and disease
Rachael A. Clark
SCIENCE TRANSLATIONAL MEDICINE (2015)
Reversal of Alopecia Areata Following Treatment With the JAK1/2 Inhibitor Baricitinib
Ali Jabbari et al.
EBIOMEDICINE (2015)
VX-509 (Decernotinib) Is a Potent and Selective Janus Kinase 3 Inhibitor That Attenuates Inflammation in Animal Models of Autoimmune Disease
Sudipta Mahajan et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2015)
Selective inhibitors of the Janus kinase Jak3-Are they effective?
Gebhard Thoma et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2014)
Epidermal Th22 and Tc17 Cells Form a Localized Disease Memory in Clinically Healed Psoriasis
Stanley Cheuk et al.
JOURNAL OF IMMUNOLOGY (2014)
Alopecia areata is driven by cytotoxic T lymphocytes and is reversed by JAK inhibition
Luzhou Xing et al.
NATURE MEDICINE (2014)
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
Michael I. Love et al.
GENOME BIOLOGY (2014)
Janus kinase inhibitors in autoimmune diseases
John J. O'Shea et al.
ANNALS OF THE RHEUMATIC DISEASES (2013)
JAK and STAT Signaling Molecules in Immunoregulation and Immune-Mediated Disease
John J. O'Shea et al.
IMMUNITY (2012)
Placebo-Controlled Trial of Tofacitinib Monotherapy in Rheumatoid Arthritis
Roy Fleischmann et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
A Double-Blind, Placebo-Controlled Trial of Ruxolitinib for Myelofibrosis
Srdan Verstovsek et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Jak1 Has a Dominant Role over Jak3 in Signal Transduction through γc-Containing Cytokine Receptors
Claude Haan et al.
CHEMISTRY & BIOLOGY (2011)
CXCR3 ligands: redundant, collaborative and antagonistic functions
Joanna R. Groom et al.
IMMUNOLOGY AND CELL BIOLOGY (2011)
Depletion of Autoreactive Plasma Cells and Treatment of Lupus Nephritis in Mice Using CEP-33779, a Novel, Orally Active, Selective Inhibitor of JAK2
Lily D. Lu et al.
JOURNAL OF IMMUNOLOGY (2011)
Double-Blind, Placebo-Controlled, Dose-Escalation Study to Evaluate the Pharmacologic Effect of CP-690,550 in Patients With Psoriasis
Mary G. Boy et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2009)
Lymphocytes, neuropeptides, and genes involved in alopecia areata
Amos Gilhar et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Interferon-γ-deficient mice are resistant to the development of alopecia areata
P. Freyschmidt-Paul et al.
BRITISH JOURNAL OF DERMATOLOGY (2006)
Resistance to alopecia areata in C3H/HeJ mice is associated with increased expression of regulatory cytokines and a failure to recruit CD4+ and CD8+ cells
KJ McElwee et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2002)
Interleukin-10-deficient mice are less susceptible to the induction of alopecia areata
P Freyschmidt-Paul et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2002)
Analysis of the expression of cutaneous lymphocyte-associated antigen on the peripheral blood and cutaneous lymphocytes of alopecia areata patients
S Yano et al.
ACTA DERMATO-VENEREOLOGICA (2002)
Transcription of the interferon γ (IFN-γ)-inducible chemokine Mig in IFN-γ-deficient mice
S Mahalingam et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Janus kinase 3 (Jak3) is essential for common cytokine receptor γ chain (γc)-dependent signaling:: comparative analysis of γc, Jak3, and γc and Jak3 double-deficient mice
K Suzuki et al.
INTERNATIONAL IMMUNOLOGY (2000)
Share Paper
